
Doctors. Drugs. Unfiltered opinions. The unvarnished truth. These are things that are rarely if ever, seen together. Here you can find an informed, objective alternative to the medical party line. Join me.
| Platform | Pricing | Freemium | Publishes | Weekly | |
|---|---|---|---|---|---|
| Issues | 70 | Subscribers | Read | drpetergrinspoon.substack.com |
Curious about how many subscribers Grinspoon on Drugs has or want to find similar newsletters? Reletter has got you covered. We collated all the information we could find from across the web in our database of over three million newsletters.
Check the email archives, get traffic estimates, engagement scores and more to discover the best advertising opportunities.
Our search tool helps you locate relevant newsletters for any topic and compare their stats for better sponsorship decisions.
Recent posts by this newsletter. Browse the email archive.
Patients aren’t allowed to bring medical cannabis into the hospital, a circumstance which confuses everyone involved. While medical cannabis is legal in thirty-eight states, it is still federally illegal and is scheduled in the most restric...
Quick note - you may have received an earlier unedited version of this newsletter on Saturday night - here is the official edited version!
In addition to my disintegrating job as a primary care doctor, I work at the addiction clinic at my hospital. We take top-rate care of anyone struggling with addiction, no matter what their circumstances. We provide low-barrier access to tr...
Because our healthcare system is failing on so many simultaneous levels, it is difficult for a veteran primary care doctor to know where to begin. I work at an inner-city clinic located in an exceptionally poor part of Boston. For one week ...
Other publications recommended by the authors of this newsletter.
The writers behind this newsletter.
Peter Grinspoon, M.D. is a primary care doctor at Massachusetts General Hospital, an Instructor in Medicine at Harvard Medical School, and has been a cannabis specialist for twenty-five years.
You can find recent issues that have been published by Grinspoon on Drugs on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to Grinspoon on Drugs, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch Grinspoon on Drugs as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Grinspoon on Drugs using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Similar Newsletters to see other publications like Grinspoon on Drugs. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.